Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03120052 · ClinicalTrials.gov registry record
Physical Therapy Components for Maximum TKR Outcome
A clinical trial, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- 161
- Enrollment target
NCT03120052: Completed study, sponsored by University of Massachusetts, Worcester.
NCT03120052 is a clinical trial that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 161 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03120052 has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- 161 participants
- Enrollment target
Study Summary
The overall goal of this study is to identify what Physical Therapy care components are associated with the best patient-reported functional outcome after Total Knee Replacement (TKR) surgery. The investigators are specifically looking at outcomes at 6 and 12 months after surgery.
Primary Outcome
Differences in pre-operative to 6 month post -operative functional gain, using the SF-36 Physical Component Summary (PCS) Score by physical therapy regimen.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2020-12-08 |
What the finished NCT03120052 record still lists
NCT03120052 is an observational study that tracks outcomes without assigning an intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03120052 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03120052 about?
NCT03120052 is a clinical study titled "Physical Therapy Components for Maximum TKR Outcome". The overall goal of this study is to identify what Physical Therapy care components are associated with the best patient-reported functional outcome after Total Knee Replacement (TKR) surgery. The investigators are specifically looking at outcomes at 6 and 12 months after surgery.
What is the current status of trial NCT03120052?
This trial is currently completed. The enrollment target is 161 participants. The study started on 2018-01-08. Estimated completion is 2020-12-08.
Who is sponsoring clinical trial NCT03120052?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI